Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
An e-mail and telephone helpline for sexual problems - results of a 2-year survey of men's sexual concerns.
Tomlinson JM, Fernandes LC, Wylie KR.
Int J Clin Pract. 2011 Oct;65(10):1085-91. doi: 10.1111/j.1742-1241.2011.02729.x. Epub 2011 Aug 1.
Related citations
Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study.
Kirby MG, Schnetzler G, Zou KH, Symonds T.
Int J Clin Pract. 2011 Jul;65(7):797-806. doi: 10.1111/j.1742-1241.2011.02693.x.
Comparison of metabolic syndrome subjects with and without erectile dysfunction - levels of circulating oxidised LDL and arterial elasticity.
Pohjantähti-Maaroos H, Palomäki A.
Int J Clin Pract. 2011 Mar;65(3):274-80. doi: 10.1111/j.1742-1241.2010.02595.x.
Complementary medicine and erectile dysfunction: will you accept the charges?
Jackson G.
Int J Clin Pract. 2011 Mar;65(3):231. doi: 10.1111/j.1742-1241.2011.02647.x. No abstract available.
Cardiovascular risk, drugs and erectile function--a systematic analysis.
Baumhäkel M, Schlimmer N, Kratz M, Hackett G, Jackson G, Böhm M.
Int J Clin Pract. 2011 Mar;65(3):289-98. doi: 10.1111/j.1742-1241.2010.02563.x. Review. Erratum in: Int J Clin Pract. 2011 Apr;65(4):516. Hacket, G [corrected to Hackett, G].
Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.
Billups KL, Miner MM, Wierzbicki AS, Jackson G.
Int J Clin Pract. 2011 Feb;65(2):134-47. doi: 10.1111/j.1742-1241.2010.02564.x. Epub 2010 Dec 29. Review.
Erectile dysfunction and testosterone screening with prostate specific antigen screening at age 40: are these three gender specific determinants additive for overall men's heath and do they improve traditional non-gender specific determinants to lessen cardiovascular risk and all-cause mortality?
Miner MM, Seftel AD.
Int J Clin Pract. 2010 Dec;64(13):1754-62. doi: 10.1111/j.1742-1241.2010.02521.x. Review.
Services for erectile dysfunction in the UK - a 12-month review of referrals to a west Midlands NHS clinic.
Hackett G, Cole N.
Int J Clin Pract. 2010 Jun;64(7):925-9.
Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus.
Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G, Montorsi P, Montorsi F, Vlachopoulos C, Kloner R, Sharlip I, Miner M.
Int J Clin Pract. 2010 Jun;64(7):848-57.
Problem solved: erectile dysfunction (ED) = early death (ED).
Int J Clin Pract. 2010 Jun;64(7):831-2. No abstract available.
Listen: testosterone is no longer a secret.
Int J Clin Pract. 2010 May;64(6):663-4. No abstract available.
The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
Gittelman M, McMahon CG, Rodríguez-Rivera JA, Beneke M, Ulbrich E, Ewald S.
Int J Clin Pract. 2010 Apr;64(5):594-603.
Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.
Giuliano F, Jackson G, Montorsi F, Martin-Morales A, Raillard P.
Int J Clin Pract. 2010 Jan;64(2):240-55. Epub 2009 Nov 9. Review.
Five-year experience with tadalafil in the UK: an effective treatment for erectile dysfunction.
Dinsmore W.
Int J Clin Pract. 2009 Aug;63(8):1231-6. Review.
Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.
Sadovsky R, Brock GB, Gutkin SW, Sorsaburu S.
Int J Clin Pract. 2009 Aug;63(8):1214-30. Review.
The burden and extent of comorbid conditions in patients with erectile dysfunction.
Hackett G.
Int J Clin Pract. 2009 Aug;63(8):1205-13. Review.
Erectile dysfunction: a harbinger for cardiovascular events and other comorbidities, thereby allowing a 'Window of Curability'.
Miner MM.
Int J Clin Pract. 2009 Aug;63(8):1123-6. No abstract available.
Erectile dysfunction and coronary artery disease: the cardiac window opens.
Int J Clin Pract. 2009 Aug;63(8):1119. No abstract available.
Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study.
Rosenberg MT, Adams PL, McBride TA, Roberts JN, McCallum SW.
Int J Clin Pract. 2009 Jan;63(1):27-34.
ENDURANCE: getting the timing right.
Int J Clin Pract. 2009 Jan;63(1):1. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on